At IDT Biologika, we are committed to your development and manufacturing needs for vaccine and cell & gene products from early stage to clinical and commercial manufacturing. We offer clients a single source CDMO partner at our sites in Germany and the USA. This includes Process Development, Drug Substance Manufacturing, Aseptic Fill-Finish, Packaging, Quality Control & Analytics. With more than 100 years of expertise in biologics manufacturing we are redefining the boundaries of innovation in commercial manufacturing for our clients. We expanded our fill-finish capacities for large molecule products (including RNA) by setting-up another aseptic high-speed filling line. Also building upon our industry leading knowledge, we help you to overcome challenges with your products by use of IDT Biologika’s next generation AAV and LV platforms. Having produced one of the first CGT products approved by the FDA and EMA, we strive to bring the next generation of therapeutics to market.